Beckman Coulter's Q3 Revenues Increase 6 Percent Despite Decline in Life Science Sales

Oct 30, 2007

NEW YORK (GenomeWeb News) - Beckman Coulter today said third-quarter revenues increased 6 percent as strong sales for its clinical diagnostics were offset by lower-than-expected sales for its life science products.

Total receipts for the three months ended Sept. 30 increased to $669 million from $631.2 million year over year.

The company said it saw an increase of 9.4 percent in clinical diagnostics, while life science products declined 8.6 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Privacy Policy Information, Please

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

Moving the Parts About

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

This Week in Science

In Science this week: genetic overlap among many psychiatric disorders, and more.

Just Skip that Step

The Economist writes that an increasing number of scientific journals don't do peer review.

Main menu